On February 6, 2024, Novo Nordisk A/S initiated a share repurchase program of up to DKK 20 billion, intending to buy back B shares worth up to DKK 2.1 billion until April 30, 2024. As of February 9, 2024, the company has repurchased 179,000 B shares at an average price of DKK 819.02 per share, totaling DKK 146,605,323.